DAFNA Capital Management as of June 30, 2023
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 73 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr S&p Biotech Etf Etf (XBI) | 12.9 | $47M | 565k | 83.20 | |
Iveric Bio | 6.6 | $24M | 613k | 39.34 | |
Stereotaxis Com New (STXS) | 5.7 | $21M | 14M | 1.53 | |
Blueprint Medicines (BPMC) | 4.3 | $16M | 252k | 63.20 | |
Revolution Medicines (RVMD) | 3.7 | $14M | 512k | 26.75 | |
Ishares Nasdaq Biotech Indx Etf (IBB) | 3.6 | $13M | 103k | 126.96 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 3.3 | $12M | 135k | 89.25 | |
Morphic Hldg (MORF) | 3.2 | $12M | 207k | 57.33 | |
Ideaya Biosciences (IDYA) | 3.1 | $11M | 480k | 23.50 | |
Cytokinetics Com New (CYTK) | 3.0 | $11M | 333k | 32.62 | |
Xenon Pharmaceuticals (XENE) | 3.0 | $11M | 281k | 38.50 | |
Merus N V (MRUS) | 2.8 | $10M | 385k | 26.33 | |
Syndax Pharmaceuticals (SNDX) | 2.6 | $9.4M | 451k | 20.93 | |
Karuna Therapeutics Ord | 2.5 | $9.1M | 42k | 216.85 | |
Dex (DXCM) | 2.4 | $8.7M | 68k | 128.51 | |
Sage Therapeutics (SAGE) | 2.3 | $8.5M | 180k | 47.02 | |
Neurocrine Biosciences (NBIX) | 1.9 | $7.0M | 75k | 94.30 | |
AtriCure (ATRC) | 1.7 | $6.2M | 126k | 49.36 | |
Day One Biopharmaceuticals I (DAWN) | 1.7 | $6.1M | 507k | 11.94 | |
Dice Therapeutics | 1.6 | $5.9M | 128k | 46.46 | |
Nurix Therapeutics (NRIX) | 1.5 | $5.6M | 557k | 9.99 | |
Kalvista Pharmaceuticals (KALV) | 1.5 | $5.5M | 611k | 9.00 | |
2seventy Bio Common Stock (TSVT) | 1.4 | $5.0M | 496k | 10.12 | |
Viking Therapeutics (VKTX) | 1.3 | $4.8M | 294k | 16.21 | |
Accuray Incorporated (ARAY) | 1.3 | $4.7M | 1.2M | 3.87 | |
Arcus Biosciences Incorporated (RCUS) | 1.3 | $4.6M | 226k | 20.31 | |
Century Therapeutics (IPSC) | 1.1 | $4.1M | 1.3M | 3.16 | |
Edgewise Therapeutics (EWTX) | 1.1 | $4.0M | 519k | 7.75 | |
BioCryst Pharmaceuticals (BCRX) | 1.1 | $4.0M | 569k | 7.04 | |
Alector (ALEC) | 1.0 | $3.8M | 639k | 6.01 | |
Kura Oncology (KURA) | 1.0 | $3.8M | 358k | 10.58 | |
Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.0 | $3.6M | 4.0M | 0.91 | |
Mirati Therapeutics | 0.9 | $3.4M | 95k | 36.13 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.9 | $3.1M | 122k | 25.52 | |
Axogen (AXGN) | 0.8 | $3.0M | 332k | 9.13 | |
Mediwound Shs New (MDWD) | 0.8 | $2.7M | 258k | 10.66 | |
Tandem Diabetes Care Com New (TNDM) | 0.7 | $2.7M | 110k | 24.54 | |
Mersana Therapeutics (MRSN) | 0.7 | $2.7M | 811k | 3.29 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.6 | $2.2M | 930k | 2.38 | |
Galapagos Nv Spon Adr (GLPG) | 0.6 | $2.1M | 53k | 40.66 | |
Adicet Bio (ACET) | 0.5 | $1.9M | 797k | 2.43 | |
Keros Therapeutics (KROS) | 0.5 | $1.9M | 48k | 40.18 | |
Regulus Therapeutics (RGLS) | 0.4 | $1.6M | 1.1M | 1.47 | |
Vigil Neuroscience (VIGL) | 0.4 | $1.6M | 172k | 9.40 | |
Proqr Therapeutics N V Shs Euro (PRQR) | 0.4 | $1.5M | 941k | 1.62 | |
Lyra Therapeutics (LYRA) | 0.4 | $1.5M | 361k | 4.11 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.4 | $1.3M | 1.0M | 1.32 | |
Iteos Therapeutics (ITOS) | 0.4 | $1.3M | 99k | 13.24 | |
Brainsway Sponsored Ads (BWAY) | 0.3 | $1.2M | 505k | 2.28 | |
Sutro Biopharma (STRO) | 0.3 | $1.1M | 243k | 4.65 | |
Larimar Therapeutics (LRMR) | 0.3 | $1.1M | 350k | 3.13 | |
Astria Therapeutics (ATXS) | 0.3 | $1.1M | 128k | 8.33 | |
Acrivon Therapeutics Common Stock (ACRV) | 0.3 | $996k | 77k | 12.96 | |
Surface Oncology | 0.3 | $957k | 1.1M | 0.87 | |
Syros Pharmaceuticals Com New (SYRS) | 0.2 | $838k | 266k | 3.15 | |
Pardes Biosciences | 0.2 | $779k | 430k | 1.81 | |
Nevro (NVRO) | 0.2 | $712k | 28k | 25.42 | |
Elevation Oncology (ELEV) | 0.2 | $684k | 450k | 1.52 | |
Neuronetics (STIM) | 0.2 | $675k | 314k | 2.15 | |
Spruce Biosciences (SPRB) | 0.2 | $671k | 312k | 2.15 | |
Biohaven (BHVN) | 0.1 | $505k | 21k | 23.92 | |
Masimo Corporation (MASI) | 0.1 | $494k | 3.0k | 164.55 | |
Compass Therapeutics (CMPX) | 0.1 | $372k | 117k | 3.18 | |
Karyopharm Therapeutics (KPTI) | 0.1 | $345k | 193k | 1.79 | |
Nextcure (NXTC) | 0.1 | $338k | 188k | 1.80 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $325k | 351k | 0.93 | |
Medicenna Therapeutics Corp. (MDNAF) | 0.1 | $318k | 660k | 0.48 | |
Procept Biorobotics Corp (PRCT) | 0.1 | $283k | 8.0k | 35.35 | |
Kinnate Biopharma | 0.1 | $243k | 80k | 3.03 | |
Compugen Ord (CGEN) | 0.1 | $234k | 205k | 1.14 | |
Lineage Cell Therapeutics In (LCTX) | 0.1 | $197k | 140k | 1.41 | |
Spero Therapeutics (SPRO) | 0.0 | $181k | 125k | 1.45 | |
Inogen (INGN) | 0.0 | $173k | 15k | 11.55 |